Published in Exp Hematol on August 01, 1983
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med (1991) 12.09
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med (1992) 6.06
Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol (1984) 4.55
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother (1993) 3.25
Localization of RNA tumor virus polypeptides. I. Isolation of further virus substructures. Virology (1973) 2.94
Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med (1993) 2.90
Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol (2006) 2.79
Exploratory and confirmatory tests of the big five and Tellegen's three- and four-dimensional models. J Pers Soc Psychol (1994) 2.56
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. Ann Intern Med (2001) 2.47
Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. Blood (1998) 2.31
Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med (1988) 2.19
Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol (1980) 2.15
Use of quantitative bacteriologic techniques to diagnose catheter-related sepsis. Arch Intern Med (1979) 2.06
Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors. J Immunol (1980) 2.04
Considerations in the isolation of rat liver nuclear matrix, nuclear envelope, and pore complex lamina. Exp Cell Res (1981) 1.99
Cross-linking of the components of lactose synthetase with dimethylpimelimidate. J Biol Chem (1975) 1.98
Cytidine deaminase and the development of resistance to arabinosyl cytosine. Nat New Biol (1971) 1.97
Amino acid sequence of flagellin of Bacillus subtilis 168. III. Tryptic peptides, N-bromosuccinimide peptides, and the complete amino acid sequence. J Biol Chem (1976) 1.92
Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol (1986) 1.82
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1987) 1.82
Characterization of the full length cDNA for murine beta-1,4-galactosyltransferase. Novel features at the 5'-end predict two translational start sites at two in-frame AUGs. J Biol Chem (1988) 1.75
Ophthalmic manifestations of leukemia. Arch Ophthalmol (1989) 1.75
Characterization of the major polypeptides of the rat liver nuclear envelope. J Biol Chem (1983) 1.75
Changes in serum colony-stimulating factor and monocytic progenitor cells during Listeria monocytogenes infection in mice. Infect Immun (1984) 1.70
Agarose derivatives of uridine diphosphate and N-acetylglucosamine for the purification of a galactosyltransferase. J Biol Chem (1972) 1.67
Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med (1986) 1.64
Bovine alpha1,3-galactosyltransferase catalytic domain structure and its relationship with ABO histo-blood group and glycosphingolipid glycosyltransferases. EMBO J (2001) 1.62
A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias. Leukemia (2010) 1.61
Bovine alpha 1----3-galactosyltransferase: isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA. J Biol Chem (1989) 1.60
Bovine galactosyltransferase: identification of a clone by direct immunological screening of a cDNA expression library. Proc Natl Acad Sci U S A (1986) 1.59
JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained. Leukemia (2006) 1.51
Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood (1999) 1.49
Leukemic retinopathy. Relationship between fundus lesions and hematologic parameters at diagnosis. Ophthalmology (1989) 1.46
Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10) Br J Haematol (1990) 1.45
The secondary leukemias: challenges and research directions. J Natl Cancer Inst (1996) 1.45
Enhancement of monocytopoiesis by granulocyte colony-stimulating factor: evidence for secondary cytokine effects in vivo. Exp Hematol (1995) 1.44
Prevention of Legionella infections in a bone marrow transplant unit: multifaceted approach to decontamination of a water system. Infect Control Hosp Epidemiol (1993) 1.44
Intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor causes a cutaneous eruption. Arch Dermatol (1991) 1.44
A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia. Clin Cancer Res (1998) 1.42
Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst (1991) 1.42
Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin. J Natl Cancer Inst (1999) 1.42
The erasable Western blot. Anal Biochem (1987) 1.41
Purification and properties of L cell-derived colony-stimulating factor. J Lab Clin Med (1979) 1.41
alpha-Interferon in myelofibrosis: a case report. Br J Haematol (1994) 1.40
Disseminated infection with Trichosporon beigelii. Rev Infect Dis (1988) 1.40
Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. Blood (1987) 1.39
Favorable outcome of invasive aspergillosis in patients with acute leukemia. J Clin Oncol (1987) 1.37
Beta 1,4-galactosyltransferase: a short NH2-terminal fragment that includes the cytoplasmic and transmembrane domain is sufficient for Golgi retention. J Biol Chem (1992) 1.37
Diagnosis and successful treatment of fusariosis in the compromised host. J Infect Dis (1988) 1.36
Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. N Engl J Med (1986) 1.35
Receptor function of mouse sperm surface galactosyltransferase during fertilization. J Cell Biol (1985) 1.34
Phase I and pharmacodynamic study of taxol in refractory acute leukemias. Cancer Res (1989) 1.31
Characterization of an alpha 1----3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene. J Biol Chem (1991) 1.31
Amino-terminal amino acid sequence of murine colony-stimulating factor 1. Proc Natl Acad Sci U S A (1985) 1.27
In vitro cytotoxic activity of Thai medicinal plants used traditionally to treat cancer. J Ethnopharmacol (2004) 1.27
Classification of Bacillus subtilis flagellins. J Bacteriol (1977) 1.25
My-1, the human myeloid-specific antigen detected by mouse monoclonal antibodies, is a sugar sequence found in lacto-N-fucopentaose III. Blood (1983) 1.23
The relationship of the nuclear matrix to cellular structure and function. Adv Enzyme Regul (1978) 1.23
Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products. J Immunol (1985) 1.20
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo. Br J Cancer (2006) 1.19
On the amino-acid sequence of flagellin from Bacillus subtilis 168: comparison with other bacterial flagellins. Proc Natl Acad Sci U S A (1973) 1.19
Stable expression of mammalian beta 1,4-galactosyltransferase extends the N-glycosylation pathway in insect cells. Glycobiology (1998) 1.19
Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy. Cancer Res (2000) 1.18
Cloning and tissue-specific expression of mouse macrophage colony-stimulating factor mRNA. Proc Natl Acad Sci U S A (1987) 1.18
Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation? J Natl Cancer Inst Monogr (2001) 1.18
Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study. Ann Intern Med (1983) 1.18
The expanding beta 4-galactosyltransferase gene family: messages from the databanks. Glycobiology (1998) 1.17
Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia. Blood (1991) 1.17
Effect of Listeria monocytogenes infection on serum levels of colony-stimulating factor and number of progenitor cells in immune and nonimmune mice. Infect Immun (1985) 1.15
Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med (1986) 1.14
Granulocyte colony stimulating factor. I. Response to acute granulocytopenia. Blood (1971) 1.14
Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood (1994) 1.14
Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. J Clin Invest (1987) 1.14
Temporally specific involvement of cell surface beta-1,4 galactosyltransferase during mouse embryo morula compaction. Cell (1988) 1.13
Multipotent marrow stromal cell line is able to induce hematopoiesis in vivo. J Cell Physiol (1992) 1.13
Fractionation of antibodies to L-cell colony-stimulating factor by affinity chromatography. Blood (1979) 1.12
Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Blood (2000) 1.12
Effect of colony stimulating factor on murine macrophages. Induction of antitumor activity. J Clin Invest (1982) 1.12
Murine alpha 1,3-galactosyltransferase. A single gene locus specifies four isoforms of the enzyme by alternative splicing. J Biol Chem (1992) 1.11
A two-step timed sequential treatment for acute myelocytic leukemia. Blood (1989) 1.11
Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int (1984) 1.11
Formaldehyde in human cancer cells: detection by preconcentration-chemical ionization mass spectrometry. Anal Chem (2001) 1.10
Simultaneous immunoelectron microscopic visualization of protein B23 and C23 distribution in the HeLa cell nucleolus. J Histochem Cytochem (1989) 1.10
Nucleolar distribution of proteins B23 and nucleolin in mouse preimplantation embryos as visualized by immunoelectron microscopy. Development (1990) 1.09